Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - microfluidics
Rapid and ultrasensitive SARS-CoV-2 antigen detection for acute COVID-19 screening in community settings
A portable point-of-care device for rapid and sensitive detection of acute SARS-CoV-2 infections. Problem: The COVID-19 pandemic has infected over 40 million people worldwide as of mid-October 2020, causing more than 1 million deaths. Up to 50-80% of transmissions occur from asymptomatic patients. Current tests can have a turnaround time of hours...
© 2021. All Rights Reserved. Powered by